Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of etomidate vs propofol on seizure quality in ECT
IRCT20260601069610N1Phase 3Completed
- Sponsor
- Baqiyatallah University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of etomidate and propofol in mental disorder (2 arms), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoint: Effective induced seizure quality and duration. Started Jul 2026; status: completed.
02
Drugs
etomidatepropofol
03
Conditions
mental disorder
Beyond the preview
Go deeper on IRCT20260601069610N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260601069610N1.